[Possibilities and limitations of cortisone therapy in internal diseases].
D000743:Anemia, Hemolytic / Q000188:drug therapy; D001249:Asthma / Q000188:drug therapy; D001991:Bronchitis / Q000188:drug therapy; D002908:Chronic Disease; D003095:Collagen Diseases / Q000188:drug therapy; D003907:Dexamethasone / Q000627:therapeutic use; D004700:Endocrine System Diseases / Q000188:drug therapy; D005938:Glucocorticoids / Q000627:therapeutic use*; D006689:Hodgkin Disease / Q000188:drug therapy; D006801:Humans; D007388:Internal Medicine; D008134:Long-Term Care; D008775:Methylprednisolone / Q000627:therapeutic use; D010195:Pancreatitis / Q000188:drug therapy; D011239:Prednisolone / Q000627:therapeutic use; D011241:Prednisone / Q000627:therapeutic use; D012216:Rheumatic Diseases / Q000188:drug therapy; D012507:Sarcoidosis / Q000188:drug therapy; D014221:Triamcinolone / Q000627:therapeutic use; D014376:Tuberculosis / Q000188:drug therapy
D005938:Glucocorticoids; D014221:Triamcinolone; D003907:Dexamethasone; D011239:Prednisolone; D011241:Prednisone; D008775:Methylprednisolone
Möglichkeiten und Grenzen einer Cortisontherapie bei inneren Erkrankungen.